Skip to content
Thursday, November 5, 2026
Explore the latest trends in technology, business strategie…

Zimbabwe Rejects ‘One-Sided’ US Healthcare Assistance Package Over Information Concerns

Health aid image
The proposed US funding would have supported initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a substantial US health deal valued at $367m (272 million pounds) over five years due to the United States' demand for confidential information.

This rejection came to light following a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the deal was "unbalanced".

A government representative later explained that the US was demanding access to genetic material for research and commercial purposes but was not willing to share the resulting advantages from any future vaccines.

"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had provided over $1.9bn in health funding to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has urged more dialogue to reach a agreement acceptable to both sides so the country's critical HIV programme can proceed.

Wider Background

This rejection follows a comparable situation in Kenya, where a high court suspended a related health funding agreement following concerns were raised about the safety of citizens' medical information.

After resuming office last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

The agency had overseen aid for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government deals to enhance transparency and responsibility.

As per statements, Sixteen African countries have so far agreed to similar agreements, representing over $18.3bn in new funding.

Details of the Rejected Agreement

The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this partnership might have yielded extraordinary advantages for Zimbabwean communities, particularly the 1.2 million currently on antiretroviral therapy through US-supported initiatives," Tremont commented.

However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".

"Our nation was requested to share its genetic material and health information over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that shared data," he stated.

"In essence, our country would supply the raw materials for scientific discovery without any certainty that the end products would be accessible to our citizens if a new pandemic emerge."

National Interest and International Frameworks

Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already established through the global health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing system created to manage potential global health emergencies.

"This framework is designed to ensure that when a country provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."

Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.

"We welcome further dialogue with our American counterparts on how future collaboration might be structured in a way that respects the sovereignty and interests of each country."

Health Experts Reaction

A leading public health body expressed it recognised the government's concerns, but recommended that negotiations should continue given that much of the country's HIV programmes depended on external financing.

"Where specific concerns exist, such as those relating to information security or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," it said.

The halted deal underscores the continuing debate between receiving much-needed international aid and protecting local interests in an increasingly data-driven world.

PG
About the author

Patricia Gibson

A tech journalist and business strategist with over a decade of experience covering global markets and digital transformation.

Spin Global Blog

Type to search articles.